| Literature DB >> 30720741 |
Muhammet Gürdoğan1, Sezgin Kehaya2, Selçuk Korkmaz3, Servet Altay4, Uğur Özkan5, Çağlar Kaya6.
Abstract
BACKGROUND AND OBJECTIVES: Cranial magnetic resonance imaging findings of patients considered to be cryptogenic stroke may be useful in determining the clinical and prognostic significance of arrhythmias, such as atrial premature beats and atrial run attacks, that are frequently encountered in rhythm Holter analysis. This study was conducted to investigate the relationship between short atrial runs and frequent premature atrial contractions detected in Holter monitors and infarct distributions in cranial magnetic resonance imaging of patients diagnosed with cryptogenic stroke.Entities:
Keywords: atrial run; cardioembolism; cryptogenic stroke; premature atrial contraction
Mesh:
Substances:
Year: 2019 PMID: 30720741 PMCID: PMC6409892 DOI: 10.3390/medicina55020038
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1Inclusion and exclusion criteria.
Figure 2(A) Representation of premature atrial contraction from the rhythm Holter analysis of a patient with infarcts in multiple vascular territories. (B) Representation of 8-beat supraventricular run from the rhythm Holter analysis of a patient with infarcts in multiple vascular territories.
Figure 3(A) and (B) single vascular territory infarction, (C) and (D) multiple vascular territory infarction.
Demographic data between single and multiple vascular territory infarcts.
| Variables | Single Vascular Territory (n = 73) | Multiple Vascular Territory (n = 33) | |
|---|---|---|---|
|
| 59.07 | 65.12 |
|
|
| |||
| Female | 21 (61.8) | 13 (38.2) | 0.278 |
| Male | 52 (72.2) | 20 (27.8) | |
|
| |||
| No | 62 (68.1) | 29 (31.9) | 0.773 |
| Yes | 11 (73.3) | 4 (26.7) | |
|
| |||
| No | 46 (64.8) | 25 (35.2) | 0.196 |
| Yes | 27 (77.1) | 8 (22.9) | |
|
| |||
| No | 40 (78.4) | 11 (21.6) |
|
| Yes | 33 (60.0) | 22 (40.0) | |
|
| |||
| No | 54 (74.0) | 19 (26.0) | 0.091 |
| Yes | 19 (57.6) | 14 (42.4) | |
|
| |||
| No | 50 (74.6) | 17 (25.4) | 0.093 |
| Yes | 23 (59.0) | 16 (41.0) | |
|
| |||
| No | 55 (71.4) | 22 (28.6) | 0.354 |
| Yes | 18 (62.1) | 11 (37.9) |
* Statistical significance (p < 0.05); descriptives: mean±SD, count (percent). Abbreviations: CAD: Coronary Artery Disease, DM: Diabetes Mellitus, HL: Hyperlipidemia, HT: Hypertension.
Distribution of laboratory data variables of patients.
| Variables | Single Vascular Territory (n = 73) | Multiple Vascular Territory (n = 33) | |
|---|---|---|---|
| Rhythm Holter Duration | 23.15 (22.00–24.00) | 23.18 (21.16–24.00) | 0.795 |
| Maximum Heart Rate | 113.63 | 112.18 | 0.3633 |
| Mean Heart Rate | 71.9589 | 75.36 | 0.113 |
| Minimum Heart Rate | 50.51 | 52.97 | 0.236 |
| Total PAC Count | 167.00 (37.00–447.00) | 1196.00 (1061.00–1813.00) | <0.001* |
| Atrial Run | 0.00 (0.00–0.00) | 13.50 (11.00–34.25) | <0.001* |
| Total Run | 11.42 (11.31–11.54) | 11.38 (11.31–11.53) | 0.286 |
| PAC/Total heart rate | 0.0018 (0.0004–0.0051) | 0.0174 (0.0098–0.0275) | <0.001* |
| EF | 60.00 (55.00–63.00) | 58.00 (55.00–60.00) | 0.337 |
| LA | 36.99 | 37.09 | 0.932 |
| LVDD | |||
| No | 29 (72.5) | 11 (27.5) | 0.530 |
| Yes | 44 (66.7) | 22 (33.3) | |
| CHA2DS2-VASc | 3.00 (2.00–5.00) | 5.00 (3.00–6.00) | 0.059 |
| logPLT | 12.36±0.45 | 12.39 ± 0.30 | 0.873 |
| logWBC | 8.96 | 8.98 | 0.790 |
| CRP | 0.60 (0.30–1.06) | 1.00 (0.40–3.20) | 0.037* |
| TSH | 0.80 (0.40–1.20) | 1.00 (0.40–1.90) | 0.479 |
| HG | 14.00 (12.70–15.00) | 13.00 (11.30–13.70) | <0.001* |
| MPV | 10.00 (9.20–10.90) | 9.60 (9.20–10.30) | 0.305 |
* Statistical significance (p < 0.05); descriptives: mean ± sd, median (25th––75th percentile), count (percent). Abbreviations: CRP: C-reactive protein, HG: Hemoglobin, EF: Ejection fraction, LA: Left atrium, LVDD: Left ventricular diastolic dysfunction, MPV: Mean platelet volume, PAC: Premature atrial contraction PLT: Platelet WBC: White blood cell, TSH: Thyroid-stimulating hormone. CHA2DS2-VASc nomenclature represents heart failure (C), hypertension (H), age ≥ 75 years (A2), diabetes mellitus (D), stroke (S2), vascular disease (V), age 65 to 74 years (A) and female gender (as a sex category [Sc]).
Univariate logistic regression analyses results for single and multiple vascular territories.
| Variable | Coefficient (Standard Error) | Odds Ratio (95% CI) | |
|---|---|---|---|
| Age | 0.034 (0.017) | 1.034 (1.001–1.068) |
|
| Gender (Female) | 0.476 (0.440) | 1.610 (0.679–3.814) | 0.280 |
| Alcohol (Yes) | −0.252 (0.626) | 0.777 (0.228–2.650) | 0.687 |
| Smoking (Yes) | −0.607 (0.473) | 0.545 (0.216–1.378) | 0.200 |
| HT (Yes) | 0.886 (0.438) | 2.424 (1.028–5.718) |
|
| DM (Yes) | 0.739 (0.442) | 2.094 (0.881–4.978) | 0.094* |
| HL (Yes) | 0.716 (0.430) | 2.046 (0.881–4.752) | 0.096* |
| CAD (Yes) | 0.424 (0.458) | 1.528 (0.622–3.752) | 0.355 |
| Rhythm Holter Duration | 0.034 (0.075) | 1.034 (0.893–1.198) | 0.652 |
| Maximum Heart Rate | −0.004 (0.011) | 0.996 (0.974–1.018) | 0.714 |
| Mean Heart Rate | 0.033 (0.021) | 1.033 (0.992–1.076) | 0.117* |
| Minimum Heart Rate | 0.026 (0.022) | 1.026 (0.983–1.070) | 0.238 |
| Total PAC Count | 0.003 (0.001) | 1.003 (1.002–1.004) |
|
| Atrial Run | 0.119 (0.030) | 1.126 (1.062–1.195) |
|
| Total Run | −0.000012 (0.000010) | 1.000 (0.999–1.000) | 0.250 |
| EF | -0.016 (0.030) | 0.984 (0.927–1.044) | 0.586 |
| LA | 0.003 (0.036) | 1.003 (0.934–1.077) | 0.931 |
| LVDD (Yes) | 0.276 (0.440) | 1.318 (0.557–3.122) | 0.530 |
| CHA2DS2-VASc | 0.220 (0.116) | 1.246 (0.993–1.565) |
|
| logPLT | 0.232 (0.553) | 1.261 (0.426–3.729) | 0.675 |
| logWBC | 0.194 (0.720) | 1.214 (0.296–4.978) | 0.787 |
| CRP | 0.162 (0.076) | 1.175 (1.014–1.363) |
|
| TSH | 0.174 (0.145) | 1.190 (0.896–1.581) | 0.230 |
| HG | −0.373 (0.127) | 0.689 (0.537–0.884) |
|
| MPV | −0.124 (0.174) | 0.884 (0.629–1.242) | 0.477 |
* p < 0.20. Abbreviations: CI: Confidence interval, CAD: Coronary artery disease, CRP: C-reactive protein, DM: Diabetes mellitus EF: Ejection fraction, HG: Hemoglobin, HL: Hyperlipidemia, HT: Hypertension, LA: Left atrium, LVDD: Left ventricular diastolic dysfunction, MPV: Mean platelet volume, PAC: Premature atrial contraction PLT: Platelet, WBC: White blood cell, TSH: Thyroid-stimulating hormone.
Multivariate logistic regression analysis result for single and multiple vascular territories.
| Variable | Coefficient (Standard Error) | Odds Ratio (95% CI) | |
|---|---|---|---|
| Age | 0.034 (0.041) | 1.035 (0.956–1.121) | 0.396 |
| HT (Yes) | 0.028 (1.145) | 1.028 (0.109–9.706) | 0.980 |
| DM (Yes) | 1.529 (0.994) | 4.612 (0.657–32.382) | 0.124 |
| HL (Yes) | 0.903 (0.981) | 2.467 (0.360–16.883) | 0.358 |
| Mean Heart Rate | 0.020 (0.040) | 1.020 (0.942–1.104) | 0.626 |
| Total PAC Count | 0.002 (0.001) | 1.002 (1.001–1.004) | 0.001* |
| Atrial Run | 0.083 (0.031) | 1.086 (1.021–1.155) | 0.008* |
| CHA2DS2-VASc | −0.872 (0.499) | 0.418 (0.157–1.112) | 0.080 |
| CRP | 0.094 (0.097) | 1.099 (0.909–1.328) | 0.332 |
| HG | −0.286 (0.214) | 0.751 (0.494–1.142) | 0.180 |
* p < 0.05. Abbreviations: CI: Confidence interval, CRP: C-reactive protein, DM: Diabetes mellitus, HL: Hyperlipidemia, HT: Hypertension, PAC: Premature atrial contraction.